Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive DisorderDavid W. Oslin, Joseph A. Simonetti, Peijun Chen et al.|JAMA|2022Cited by 182
Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran ProgramDerek Klarin, Iftikhar J. Kullo, Shefali S. Verma et al.|Circulation|2020Cited by 145
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Daniel Prieto‐Alhambra, Anthony G. Sena et al.|Lara D. Veeken|2021Cited by 53
Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network studyAnastasiya Nestsiarovich, Christophe G Lambert, Jenna Reps et al.|Translational Psychiatry|2021Cited by 51
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular OutcomesRohan Khera, Patrick B. Ryan, Arya Aminorroaya et al.|Journal of the American College of Cardiology|2024Cited by 33